Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.8 USD | +5.43% | +5.75% | +20.35% |
05-09 | Stifel Adjusts Price Target on C4 Therapeutics to $14 From $13, Maintains Buy Rating | MT |
05-08 | C4 Therapeutics Shares Decline as Q1 Revenue Misses Estimates | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.35% | 444M | |
+23.37% | 46.71B | |
+48.83% | 41.8B | |
-0.94% | 41.52B | |
-5.86% | 29.55B | |
+11.29% | 25.78B | |
-20.92% | 19.26B | |
+3.20% | 12.14B | |
-2.67% | 12.08B | |
+30.23% | 11.98B |
- Stock Market
- Equities
- CCCC Stock
- News C4 Therapeutics, Inc.
- HC Wainwright Adjusts Price Target on C4 Therapeutics to $35 From $63, Reiterates Buy Rating